MedPath

Is ballistic strength training more effective than usual care for improving mobility following traumatic brain injury (TBI)?

Not Applicable
Completed
Conditions
Traumatic Brain Injury
Mobility Limitations
Neurological - Other neurological disorders
Physical Medicine / Rehabilitation - Physiotherapy
Injuries and Accidents - Other injuries and accidents
Registration Number
ACTRN12611001098921
Lead Sponsor
Epworth Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
131
Inclusion Criteria

Participants must have a neurologically based movement disorder affecting mobility as a result of TBI and be less than 12 months post injury.

Exclusion Criteria

- were unwilling or unable to provide informed consent
- have a previously diagnosed central nervous system disorder
- have severe cognitive or behavioural problems that prevent assessment
- have orthopaedic injuries restricting mobility

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
High-Level Mobility Assessment Tool (HiMAT)[End of 12 week intervention phase<br>3 month follow-up]
Secondary Outcome Measures
NameTimeMethod
Self-selected walking speed[End of 12 week intervention phase<br>3 month follow-up];Balance - Single limb support time (left and right legs, eyes open and eyes closed)[End of 12 week intervention phase<br>3 month follow-up];Strength - 6RM seated leg press[End of 12 week intervention phase<br>3 month follow-up];Quality of Life (AQoL-6D)[End of 12 week intervention phase<br>3 month follow-up];Muscle Power Generation<br><br>Participants will be asked to perform a one-legged jump on their more-affected leg whilst lying on a reclined leg sled (LS). Participants will complete a series of five jumps at 50% of 1RM (as calculated during the muscle strength testing). The displacement occurring during each repetition will be recorded using a string potentiometer sampling at 200Hz, with data acquired via a customized LabVIEW software program (National Instruments, USA). [End of 12 week intervention phase and 3 month follow up ]
© Copyright 2025. All Rights Reserved by MedPath